{"name":"Dexa Medica Group","slug":"dexa-medica-group","ticker":"","exchange":"","domain":"dexamedica.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":9,"colorKey":"oncology","drugs":[{"name":"placebo tablet of DLBS1033","genericName":"placebo tablet of DLBS1033","slug":"placebo-tablet-of-dlbs1033","indication":"Other","status":"marketed"},{"name":"DLBS1442 100","genericName":"DLBS1442 100","slug":"dlbs1442-100","indication":"Other","status":"phase_2"},{"name":"DLBS3233","genericName":"DLBS3233","slug":"dlbs3233","indication":"Non-alcoholic fatty liver disease (NAFLD)","status":"phase_3"},{"name":"Placebo caplet of Metformin XR","genericName":"Placebo caplet of Metformin XR","slug":"placebo-caplet-of-metformin-xr","indication":"Control arm in Phase 3 clinical trial of Metformin XR","status":"phase_3"},{"name":"Placebo capsule of DLBS3233","genericName":"Placebo capsule of DLBS3233","slug":"placebo-capsule-of-dlbs3233","indication":"Other","status":"phase_3"},{"name":"Placebo of Reconyl","genericName":"Placebo of Reconyl","slug":"placebo-of-reconyl","indication":"Treatment of symptoms in clinical trials","status":"phase_3"},{"name":"Proliverenol","genericName":"Proliverenol","slug":"proliverenol","indication":"Other","status":"phase_2"},{"name":"Reconyl","genericName":"Reconyl","slug":"reconyl","indication":"Other","status":"phase_3"},{"name":"Silfamin","genericName":"Silfamin","slug":"silfamin","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"placebo tablet of DLBS1033","genericName":"placebo tablet of DLBS1033","slug":"placebo-tablet-of-dlbs1033","phase":"marketed","mechanism":"A placebo tablet containing no active pharmaceutical ingredient, used as a control comparator in clinical trials.","indications":[],"catalyst":""},{"name":"DLBS1442 100","genericName":"DLBS1442 100","slug":"dlbs1442-100","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"DLBS3233","genericName":"DLBS3233","slug":"dlbs3233","phase":"phase_3","mechanism":"DLBS3233 is a bioactive fraction derived from Cinnamomum burmannii that modulates lipid metabolism and reduces hepatic steatosis through multiple pathways.","indications":["Non-alcoholic fatty liver disease (NAFLD)"],"catalyst":""},{"name":"Placebo caplet of Metformin XR","genericName":"Placebo caplet of Metformin XR","slug":"placebo-caplet-of-metformin-xr","phase":"phase_3","mechanism":"This is a placebo formulation with no active pharmacological mechanism.","indications":["Control arm in Phase 3 clinical trial of Metformin XR"],"catalyst":""},{"name":"Placebo capsule of DLBS3233","genericName":"Placebo capsule of DLBS3233","slug":"placebo-capsule-of-dlbs3233","phase":"phase_3","mechanism":"This is a placebo capsule used as a control in clinical trials of DLBS3233.","indications":[],"catalyst":""},{"name":"Placebo of Reconyl","genericName":"Placebo of Reconyl","slug":"placebo-of-reconyl","phase":"phase_3","mechanism":"This drug is a placebo, meaning it has no active therapeutic effect.","indications":["Treatment of symptoms in clinical trials"],"catalyst":""},{"name":"Proliverenol","genericName":"Proliverenol","slug":"proliverenol","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Reconyl","genericName":"Reconyl","slug":"reconyl","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Silfamin","genericName":"Silfamin","slug":"silfamin","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxOdnV6bnNuMWYyWFRSV3FEc1FnVzBtQ3loZ1V5MDFGMEFNNmZ6VnBRcTBJTUNfSVM1dlhCTVNmdEdBa1EwczAzQ19hellYUkZkUEx6N3JpelBlUndTUU1zbkt3SDIyQzh2YnlKR242YzA3a1J6ZXhDLWlkcnpJZG43Yl9YSDB5VjktN19ldlhZY1FoZXJELW5UYW4yclJIVXNIbXdlMTlR0gGrAUFVX3lxTFA1SUk3YVF0S2s4OEptMXdHLUY5WkhxUENhLWsxenpKZzFMZ21LVW1xd2Q4SEhPb016b3dFek9LSGNHWlRhbzg2d2tEU0VqQkg0OU1uR0phd3g1ZGxhRVRuN2ItbU9KZG90d3BhUHVjTTE4TVoxYkFReXpXVGtxRjZBYWVidjdTekJnM2VqR0hHWWM5TEdMajdmd1RVWWwzeHBZM0dfMTlVai1LNA?oc=5","date":"2025-08-11","type":"pipeline","source":"ANTARA News","summary":"Dexa group expands reach, strengthens Philippine healthcare access - ANTARA News","headline":"Dexa group expands reach, strengthens Philippine healthcare access","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQRkNxUVQtRmJBOEZpZEJFNGd5eC1BQjlUZXJnSnBNVmptX0w4NFExSkZ1dTR2MVhLYllSbmxfTnlFUjJzWkF0OWVBY3MwcnhsOVYweW9iWV9KdzFCSDBzOV9pQ1AtTmRBVWxLUzZYcmt0VGhyVnd4TE5EaHdvTDlXNklxZDU4Tk9Cd2hZaW94aHI4a1d4OWhoMHdHaFBMU0U?oc=5","date":"2025-08-08","type":"pipeline","source":"Manila Bulletin","summary":"Ayala Healthcare forges strategic alliance with Indonesia’s Dexa Group - Manila Bulletin","headline":"Ayala Healthcare forges strategic alliance with Indonesia’s Dexa Group","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxPNnl0TFZvUjFYTGFIZ2VrSVQzSlpaU0NJQUZqdlQtS3BraGNsUVd6OEYybF8xQ2Z5STBEeURJRHlJeXFvQ2RtaE9fd3RfSzk4ekVodDZVaGpxN05uakZxdEpWNUVRM1VvRm1YaUJYTTNfRGo1LTZpa1RPYnZhY0JsX3E1ZzBMRTRPWktyeVRwSTM5RnhqaHV0dml0YUROVFE?oc=5","date":"2025-03-29","type":"pipeline","source":"Khmer Times","summary":"Dexa Medica: 25 Years of Healthcare Excellence for Cambodia - Khmer Times","headline":"Dexa Medica: 25 Years of Healthcare Excellence for Cambodia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTE1fblZxdW5hdXU4WUZrNmxvcmt5UXBsdm1nelcxOUQwNkZiZVppdjFHZXg4LWRBQ3cweTNrbHZvMHBuTDZudm1va1d4RkdKTWNUcWsybi03bDVfUUlGUzRha3V4NGYwWU1aYkRQa1pXNEQ?oc=5","date":"2023-04-21","type":"pipeline","source":"Punch Newspapers","summary":"Pharmaceutical firm promotes school sports - Punch Newspapers","headline":"Pharmaceutical firm promotes school sports","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxOYjF1TmVIRVNkd2VsbEFEUDVORFd5ZlM4Y1BqQlZRaWtmaFNraTZ2Y3EtZEZXYWlsV0x2SXF6TTNUcHhSUTM4b1hMR1FkdHhJZzV3ZEVpeE9hY29KeFczM1ZDSTVYaEJNSUNDbTJjdkxaTENtaEF1aDhHYm9BWUlEM0I3QnJHdlpMWGxJTUdKbnh1SmxWaDlBN2RJUnJFcHZRUW8tSlZQOVpmS2gtcEdyR3JB?oc=5","date":"2023-03-23","type":"pipeline","source":"The Guardian Nigeria News","summary":"Dexa Medica reassures promotion of healthcare, sports, education in Nigeria - The Guardian Nigeria News","headline":"Dexa Medica reassures promotion of healthcare, sports, education in Nigeria","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxNZENSZkdCSmFzVEpwbzZtb081RUs0SngzUlJvOHdPVGVhclpjQk5RSWt3anJVSUtPcDlCWGVmWWV5NVViUURKd0ZxWVRiSEVyeXRDSlRMek1uTnJ0QXo4THl5anRBSU1fWHJ2UnVRWmJJQS03bVZlZHJlTWp1TXVjU1VOc0JMai1Rd1oxcVpPblRjNC1RUFctV0JJSGNManBKQUpGQWJWOWNYQS1fWld5WnJUbFNEdHZzYnc?oc=5","date":"2023-03-01","type":"pipeline","source":"Khmer Times","summary":"Expanding Distribution Range, Dynamic Argon Launches New Branch in Kampong Cham - Khmer Times","headline":"Expanding Distribution Range, Dynamic Argon Launches New Branch in Kampong Cham","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE5wb0JCM1hsdUU4cWNCN1p1Z3cxQmhQZ05KcmdfSHd2WEppTWpUaGdXNlpWYWt3RTh5dVBmdm1aX2tOTU9nNW9uQWhUNkhzcXBzWUVrT0VsbGhpZHdLQWJBZlZ2SHVfanpFVHZzcGExQlhqaWVMWnRESWdB?oc=5","date":"2022-09-13","type":"pipeline","source":"Daily Trust","summary":"Firm Pledges Support For Healthcare Management - Daily Trust","headline":"Firm Pledges Support For Healthcare Management","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxQVm9RV2F3WElxMy1hLWxfenU4Y1g2TXRMWVZ4WUVSMWdkSktVWldsLVItVWFMc01sSEk4dTU3ZVJuRmRTZG43T0g4UmVSS2VtdjJSa3BlMWxZVWZoaUpWVXZFVmhDWGFVdk9wekwyX1FzOHpWNEtoWFFDSEFEVW9nTjJtMVY5MzFQOU55UWZqaVR3Z3hGQXJtQl93V1ZfM1JwUVpsNlpWTUoxU2tPdUc3WQ?oc=5","date":"2020-08-05","type":"pipeline","source":"PharmTech.com","summary":"Between Rocks and Hard Places: The Southeast Asian Pharmaceutical Industry at a Juncture - PharmTech.com","headline":"Between Rocks and Hard Places: The Southeast Asian Pharmaceutical Industry at a Juncture","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTE5aYlVDV3UzZFhJRHFhZEx0OTlTSG83cFo0NEhfXy0zRnVqTk5JV0E3VVRLdDFSQXQzUWs2SnctdE0xdFFDbmFCUlhVeUc0azZoLTZoV1JBQWZobHpod1luc1lKWlRKMTJ5ZnZFT293bm1BQjFx?oc=5","date":"2020-07-25","type":"pipeline","source":"The Guardian Nigeria News","summary":"Orange Group: 32years of quality products - The Guardian Nigeria News","headline":"Orange Group: 32years of quality products","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxNa1h5NVVPSVd0Z2gxc01LaDJnRjdaRjFuQkhNQVRUbkk3bl9VcWlCZldnTHFtTEpMbXBEdi1hbDd0RVdLd1FNTGVzb0ZRcU1JNkxIempUdUJHcUQ1YUV0dEhGMjNfbVVUc2NpUnEyZ2l4ZUhtV3E0MkF6eHRWNFhuUHlLWHFmYkR0azRWU3FjUzU5UzBPMmJMcWxwNldsUdIBowFBVV95cUxQcE13THRYSVNYcDNZR0ZSLWJSa1NyY1o0NzRUdDFkdXhzSjNma0FBNXZfMnlLQnRpSF95MnExQUZWck4zSmZ3MWVmR1p3SHlPZERabDdZN0RsZERaaTlWc05IVE5oUFJmZmYxd2VWTUJIVkVDdDlvVTZGazB4VjhaTkhldGxzeWowRDBEamxPNm81SnpVMGRzSFV1RkltMkJGZVBB?oc=5","date":"2020-07-21","type":"pipeline","source":"thesun.ng","summary":"Orange Group plans to leverage technology as company celebrates 32 anniversary - thesun.ng","headline":"Orange Group plans to leverage technology as company celebrates 32 anniversary","sentiment":"neutral"}],"patents":[],"drugCount":9,"phaseCounts":{"marketed":1,"phase_2":3,"phase_3":5},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}